HaiBoMaib Atorvastatin Calcium Tablets of Haizheng Pharmaceutical with new specifications approved for clinical use.

On March 17th, Haisco Pharmaceutical, a wholly-owned subsidiary of Hanzhi Pharmaceutical Co., Ltd., received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration for the new specification of Haibomaibuatofastatin calcium tablets. After review, it was approved to directly conduct Phase I and Phase III clinical trials for this product.